EMERGING TRENDS IN LUNG CANCER DIAGNOSIS AND THERAPHY

Lung cancer is one of the leading causes of cancer worldwide, representing a major global health challenges. This review focuses on recent advancements in the treatment of lung cancer, with particular emphasis on immunotheraphy and emerging therapeutic strategies. In recent years, how immunotheraphy have transformed lung cancer management by enhancing the body immune response against tumor cells. Emerging approaches, including cancer vaccines, CAR-T cell therapy, oncolytic viruses, are currently being explored to overcome these limitations and improve treatment outcomes. Overall continued research and the development of personalised treatment strategies are essential for improving survival rate and achieving better clinical outcomes in lung cancer patients.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-12
DOI
https://doi.org/10.5281/zenodo.20130859
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EMERGING TRENDS IN LUNG CANCER DIAGNOSIS AND THERAPHY

Gourav Kumar Gourav
Zenodo (CERN European Organization for Nuclear Research)
Immunotherapy and Immune Responses
article

EMERGING TRENDS IN LUNG CANCER DIAGNOSIS AND THERAPHY

Gourav Kumar Gourav
article en

Abstract

Lung cancer is one of the leading causes of cancer worldwide, representing a major global health challenges. This review focuses on recent advancements in the treatment of lung cancer, with particular emphasis on immunotheraphy and emerging therapeutic strategies. In recent years, how immunotheraphy have transformed lung cancer management by enhancing the body immune response against tumor cells. Emerging approaches, including cancer vaccines, CAR-T cell therapy, oncolytic viruses, are currently being explored to overcome these limitations and improve treatment outcomes. Overall continued research and the development of personalised treatment strategies are essential for improving survival rate and achieving better clinical outcomes in lung cancer patients.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 8%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.